---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002448"
form_type: "8-K"
ticker: "PTIX"
cik: "0001022899"
company_name: "Protagenic Therapeutics, Inc.new"
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-27T23:42:24.101947+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Protagenic Therapeutics gets Nasdaq notice for missing annual meeting; sets Feb 21, 2025 meeting

## Summary
- Received Nasdaq notice on Jan 15, 2025 for failing to hold annual meeting within 12 months of FY 2023 end (Listing Rule 5620(a)).
- Company has scheduled annual meeting to occur no later than February 21, 2025 to regain compliance.
- No immediate effect on listing of PTIX or PTIXW on Nasdaq Capital Market.
- Will submit matter to Nasdaq Hearings Panel as part of ongoing listing discussions.

## SEC filing metadata
- accession: 0001493152-25-002448
- form_type: 8-K
- ticker: PTIX
- cik: 0001022899
- company_name: Protagenic Therapeutics, Inc.new
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022899/000149315225002448/0001493152-25-002448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022899/000149315225002448/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002448
- JSON: https://secwatch.observer/filing/0001493152-25-002448.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002448.txt

## Source-grounded claims
- claim_id: fc67d2813ee1493d93d4b5c853e19dfd20d2504a
  claim: Protagenic Therapeutics, Inc.new received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).
  evidence_excerpt: January 15, 2025, Protagenic Therapeutics, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications department (“Nasdaq”) regarding the timing of its annual meeting of shareholders. Nasd
  evidence_url: https://www.sec.gov/Archives/edgar/data/1022899/000149315225002448/0001493152-25-002448-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.